Abstract
Objective To investigate the impact of age, comorbidity, and vaccination in the fatality of older COVID-19 patients in the state of Kerala, India, based on their comorbidity and vaccination status.
Methods It is a cross sectional study adopting a mixed method approach conducted among the older population in Kerala. To study the health profile, 405 older people were surveyed, and 102 people were interviewed in-depth at their households, between June to November 2020. The results of the study were triangulated with elderly COVID-19 fatality data, available from the citizen-science dashboards of the research team and Department of Health, Kerala. Vaccination data was retrieved from cowin.gov.in to study its impact. The data was analysed using the IBM SPSS version 22.0.
Results Age is a predictor of COVID-19 fatality. Diabetes, hypertension, heart diseases, CKD and COPD are the significant predictors of elderly COVID-19 fatality. The current comorbidity profile of the total older population matches with the comorbidities of the COVID-19 elderly death cases. Vaccination has impacted COVID-19 mortality after vaccinating 65 percent (first dose) of the elderly.
Conclusions Age and comorbidities can predict potential fatality among older COVID-19 patients. Timely and accurate health data and better knowledge of high-risk factors such as comorbidity can easily guide the healthcare system and authorities to efficient prevention and treatment methodologies. Knowledge on prevailing NCDs can drive early preparedness before it converges with an epidemic like the present zoonotic disease. Priority must be given for elderly vaccination to bring down the mortality rates.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The first author acknowledges financial support from the Indian Council for Social Science Research under the IMPRESS grant (F.No. IMPRESS/P1132/428/2018-19/ICSSR).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The entire study was conducted following the guidelines and ethical approval received from the Indian Council for Social Science Research (F.No. IMPRESS/P1132/428/2018-19/ICSSR). Informed consent was obtained from the respondents before collecting their data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Parts of the article revised to incorporate some recent results and numbers.
Data Availability
The COVID-19 infection, recovery and fatality datasets generated and analyzed during the current study are available in the DHS dashboard [https://dashboard.kerala.gov.in] and the citizen-science dashboard maintained by the CODD-K consortium [https://covid19kerala.info]. Comorbidity data and death reports are available from the DHS website [https://dhs.kerala.gov.in/advisories]. Vaccination data is available from the Co-WIN website [https://www.cowin.gov.in]. The datasets on health status of older adults collected for this study are not publicly available but are available from the corresponding author upon reasonable request.
